Sieć Badawcza Łukasiewicz – Instytut Chemii Przemysłowej im. Prof. Ignacego Mościckiego
Sieć Badawcza Łukasiewicz – Instytut Chemii Przemysłowej im. Prof. Ignacego Mościckiego is recorded as a service provider in 3 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 3 of 3 trials · Latest update first
Optimization of the duration of treatment and dosing of vemurafenib in pediatric patients with histiocytic cell neoplasms refractory to conventional therapy and with a BRAF gene mutation
Sponsor Instytut Matki I Dziecka
- Start (EU)
- Latest update
- Estimated end
- Not reported
Optimalization Of The Time And Dosage Of Trametinib In BRAF Negative Juvenile Patients With Refractory Histiocytosis Or After Failure Of Vemurafenib Treatment.
Sponsor Instytut Matki I Dziecka
- Start (EU)
- Latest update
- Estimated end
- Not reported
To evaluate the efficacy and safety of regorafenib in patients with refractory primary bone tumors.
Sponsor Instytut Matki I Dziecka
- Start (EU)
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for Sieć Badawcza Łukasiewicz – Instytut Chemii Przemysłowej im. Prof. Ignacego Mościckiego?
The 2026-10-09 snapshot links Sieć Badawcza Łukasiewicz – Instytut Chemii Przemysłowej im. Prof. Ignacego Mościckiego to 3 distinct CTIS trials. Recorded services include Laboratory services, pharmacokinetics. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Sieć Badawcza Łukasiewicz – Instytut Chemii Przemysłowej im. Prof. Ignacego Mościckiego?
The most frequently recorded therapeutic areas are Haematological Malignancies. Study-phase tags are not recorded. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Sieć Badawcza Łukasiewicz – Instytut Chemii Przemysłowej im. Prof. Ignacego Mościckiego conducted?
The linked trials record locations in 1 country, including Poland. These are trial locations, not confirmed office locations or countries where Sieć Badawcza Łukasiewicz – Instytut Chemii Przemysłowej im. Prof. Ignacego Mościckiego delivered services.
What can this page tell me about Sieć Badawcza Łukasiewicz – Instytut Chemii Przemysłowej im. Prof. Ignacego Mościckiego's trial experience?
Browse 3 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 2 recorded name variants under Sieć Badawcza Łukasiewicz – Instytut Chemii Przemysłowej im. Prof. Ignacego Mościckiego. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Sieć Badawcza Łukasiewicz - Instytut Chemii Przemysłowej im. Prof. Ignacego Mościckiego
- Sieć Badawcza Łukasiewicz – Instytut Chemii Przemysłowej im. Prof. Ignacego Mościckiego